Alzheimer's Disease

Alzheimer’s is a Multifactorial Disease;

The Genetic and Biochemical Basis of Alzheimer’s Disease;

Alzheimer’s Disease Pathology: A Tau Perspective;

Structural Insights Into the Amyloidogenic Ab and Tau Species in Alzheimer’s disease Pathophysiology: Defining Functional Motifs for Therapeutic Interventions;

Structural Insights on Aggregation Species of Ab and Tau, and Their Implications in Alzheimer’s Disease;

Aggregation Species of Amyloid-b and Tau Oligomers in Alzheimer’s Disease: Role in Therapeutics and Diagnostics;

Role of Metal Ions in Alzheimer’s Disease: Mechanistic Aspects Contributing to Neurotoxicity;

Microglial Blockade of the Amyloid Cascade: A New Therapeutic Frontier;

Post-translational Modifications and Alzheimer’s Disease;

Autophagy: Role in Alzheimer’s Disease Pathophysiology and Therapeutic Avenues;

Transmission of Pathogenic Proteins and the Role of Microbial Infection in Alzheimer’s Disease Pathology;

The Role of Gut Microbiome in Alzheimer’s Disease and Therapeutic Strategies;

Molecular Probes for the Diagnosis of Alzheimer’s Disease with Implications for Multiplexed and Multimodal Strategies;

Circulating Biomarkers for the Diagnosis of Alzheimer’s Disease;

Lactoferrin: A Potential Theranostic Candidate for Alzheimer’s Disease;

Multifunctional Inhibitors of Multifaceted Ab Toxicity of Alzheimer’s Disease;

Tau-targeting Therapeutic Strategies for Alzheimer’s Disease;

Computational Development of Alzheimer’s Therapeutics and Diagnostics;

Targeted Protein Degradation as a Therapeutic Avenue for Alzheimer’s Disease;

Cell-based Therapy for Alzheimer’s Disease;

Experimental Models to Study Alzheimer’s Disease;

Ethnic and Racial Differences in The Pathophysiology of Alzheimer’s Disease